GSK melanoma drug combination wins accelerated U.S. approval

Home › GSK melanoma drug combination wins accelerated U.S. approval

A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has won accelerated approval from U.S. regulators.

20.05	Sheboygan Paint Company Appoints New Technical Sales Representative
20.05	GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05	Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05	Canada invests over $9.6M to prevent, prepare for African swine fever
20.05	Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05	Pretty Little Thing warned over 'misleading' ads
20.05	Several pork priorities secured in House Farm Bill
20.05	BT scraps digital landline switch deadline
More »

je.st